ADD ANYTHING HERE OR JUST REMOVE IT…
  • About Us
    • Scientific Advisory
  • Technology
  • Products
  • Clinical Solutions
    • Cardiothoracic Surgery
    • Vascular Surgery
    • Urology Surgery
    • General Surgery
  • Distributor
  • Resources
    • Events
    • News
    • Publications
  • Contact Us
Let's Connect +1 (949) 670 0403
Tisgenx
Menu
  • About Us
    • Scientific Advisory
  • Technology
  • Products
  • Clinical Solutions
    • Cardiothoracic Surgery
    • Vascular Surgery
    • Urology Surgery
    • General Surgery
  • Distributor
  • Resources
    • Events
    • News
    • Publications
  • Contact Us

Monthly Archives: April 2023

Home2023AprilPage 4
General

Stabilization of after-traumatic flail chest by minimally invasive modified NUSS procedure in patient with starting respiratory insufficiency

Posted by author-avatar admin
April 12, 2023
0
A flail chest is one of the possible medical conditions suffered by individuals who were injured in traffic accidents, caused by multiple fractures of the ribs and sternum. Which often results in paradoxical c...
Continue reading
General

Oxygenated right ventricular assist device as part of veno-venopulmonary extracorporeal membrane oxygenation to support the right ventricle and pulmonary vasculature

Posted by author-avatar admin
April 12, 2023
0
COVID–19 infection can lead to severe acute respiratory distress syndrome (ARDS), right ventricular (RV) failure and pulmonary hypertension. Venovenous extracorporeal membrane oxygenation (V-V ECMO) has been u...
Continue reading
General

Reconstruction of the upper gastrointestinal tract using intra-thoracic Roux-en-Y technique after caustic agent ingestion: a case report from Aleppo, Syria

Posted by author-avatar admin
April 12, 2023
0
Caustic substance ingestion is a high-risk medical emergency associated with high mortality and morbidity. To date, there are several treatment options with no standard method of care.
Continue reading
General

Intravenous enoxaparin as alternative ECMO anticoagulation over a period of 94 days: a case report

Posted by author-avatar admin
April 12, 2023
0
Unfractionated heparin is used worldwide as a standard anticoagulation therapy for extracorporeal membrane oxygenation (ECMO) machines. However, its use brings about significant bleeding and thrombotic complic...
Continue reading
General

Cardiac endothelial sarcoma with hypereosinophilia of children: a case report

Posted by author-avatar admin
April 11, 2023
0
Cardiac malignancies in children are extremely rare and they with hypereosinophilia are rather relatively uncommon. The majority of individuals may survive over the long term even with heart tumors provided th...
Continue reading
General

The effects of differing anticoagulant regimes on blood quality after cell salvage in coronary artery bypass grafting (CABG): a pilot study

Posted by author-avatar admin
April 11, 2023
0
Cell salvage reduces allogenic blood transfusion requirements in surgery. We present a pilot study exploring the impact of anticoagulant choice, citrate or heparin, on the quality of cell salvaged blood in adu...
Continue reading
General

Cardiac endothelial sarcoma with hypereosinophilia of children: a case report

Posted by author-avatar admin
April 10, 2023
0
Cardiac malignancies in children are extremely rare and they with hypereosinophilia are rather relatively uncommon. The majority of individuals may survive over the long term even with heart tumors provided th...
Continue reading
General

Venoarterial extracorporeal membrane oxygenation for cardiac support in human immunodeficiency virus-positive patients: a case report and review of a multicentre registry

Posted by author-avatar admin
April 9, 2023
0
Human immunodeficiency virus (HIV) is associated with increased risk of heart failure via multiple mechanisms both in patients with and without access to highly active antiretroviral therapy (HAART). Limited i...
Continue reading
General

Effectiveness of pharmacological cardioversion of new-onset atrial fibrillation during thoracic surgery operations: a single-centre experience

Posted by author-avatar admin
April 9, 2023
0
Prophylactic pharmacological conversion agents could reduce the incidence of postoperative atrial fibrillation (AF) in patients undergoing thoracic operations. The current study examined whether the use of pha...
Continue reading
General

Grading criteria for venous invasion in thoracic esophageal squamous cell carcinoma

Posted by author-avatar admin
April 9, 2023
0
Venous invasion (VI) is an adverse prognostic indicator in esophageal squamous cell carcinoma. However, grading criteria for venous invasion in thoracic esophageal squamous cell carcinoma (ESCC) have not been ...
Continue reading
  • «
  • ‹
  • 2
  • 3
  • 4
  • 5
  • 6
  • ›
  • »
Close

Recent Posts

  • Impact of the COVID-19 pandemic on admission trends, diagnosis patterns, and demographics of ischemic heart disease patients: a retrospective study
  • In Vivo Preclinical Testing of a Bridging Stent for Fenestrated Endovascular Repair Using a Dedicated Swine Pararenal Aneurysm Model
  • Managing the Giant: A Novel Approach in Orthotopic Heart Transplantation With Extreme Left Atrial Enlargement
  • Aortic and mitral valve repair in a child with rheumatic heart disease
  • Impact of the COVID-19 pandemic on admission trends, diagnosis patterns, and demographics of ischemic heart disease patients: a retrospective study

Recent Comments

  1. A WordPress Commenter on Hello world!

Archives

  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022

Categories

  • Uncategorized
  • General
  • Tisgenx

Quick Links

  • About Us
  • Technology
  • Products
  • Distributor
  • Resources

Clinical Solutions

  • Cardiothoracic Surgery
  • Vascular Surgery
  • Urology Surgery
  • General Surgery

Resources

Brand Names

  • Events
  • News
  • Publications
  • Invengenx®
  • Vascugenx®
  • Urogenx®
  • Surgenx™

Contact Info

Address:

15615 Alton Parkway, Suite 450, Irvine, CA 92618

Phone:

+1 (949) 670-0403

Email:

info@tisgenx.com

Copyright © 2025 TisgenX. Privacy Policy. All Rights Reserved.
Close
  • About Us
    • Scientific Advisory
  • Technology
  • Products
  • Clinical Solutions
    • Cardiothoracic Surgery
    • Vascular Surgery
    • Urology Surgery
    • General Surgery
  • Distributor
  • Resources
    • Events
    • News
    • Publications
  • Contact Us
Shop
Sidebar